Market Introduction
Eye supplements are nutritional products which care recommended to maintain eye health and good vision. The eye health supplements prominently comprises vitamin A, lutein & Zeaxanthin, omega 3 fatty acids, gamma-linoleic acid, and others. These nutritional supplements helps to sustain eye function, reduce the development of age-related eye diseases, and protect eyes against harmful light. Eye health supplements can be useful over range of eye diseases such as dry eye, age-related macular degeneration, glaucoma, diabetic retinopathy, and cataracts amongst others. Increasing prevalence of eye diseases coupled with aging population is likely to drive the growth of the eye health supplement market during the forecast period.
Market Dynamics
The North America Eye Health Supplement market is expected to reach US$ 746.34 million by 2027 from US$ 509.53 million in 2019; it is anticipated to grow at a CAGR of 5.0% during 2019–2027. Factors such as growing prevalence of eye diseases and aging population are expected to boost the growth of the Eye Health Supplement market in the coming years. However, the market is likely to get impacted by the risk factor such as high cost of supplements and lack of product availability in emerging countries during the forecast period.
COVID-19 pandemic has become the most significant challenge across the North America region. This challenge will be frightening the countries across the region as it will lead to reducing imports due to disruptions in global trade, which further increases the shortages of eye health supplements, resulting in a considerable price increase. Manufacturers are also experiencing raised prices and potential shortages of raw ingredients due to supply restrictions.
Market Scope
The scope of the North America Eye Health Supplement market includes ingredient type, indication, forms and country. In terms of ingredient types, the Lutein and Zeaxanthin segment accounted for the largest share of the North America Eye Health Supplement market in 2019. In terms of indication, the Age-related Macular Degeneration (AMD) segment accounted for the largest share of the North America Eye Health Supplement market in 2019. The capsule segment accounted for the largest share of the North America Eye Health Supplement market, by forms, in 2019.
Major Sources and Companies Listed
Several major primary and secondary sources associated with the North America Eye Health Supplement market report are the World Health Organization (WHO), Centers of Disease Control and Prevention (CDC), American Academy of Ophthalmology, and US Food and Drug Administration, among others.
Reasons to Buy Report
- It provides understanding of the North America, Eye Health Supplement market landscape and identifies Eye Health Supplement market segments that are most likely to guarantee a strong return.
- It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the North America Eye Health Supplement market.
- It helps efficiently plan merger and acquisition, and partnership deals in the Eye Health Supplement market by identifying market segments with the most promising probable sales.
- It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of Eye Health Supplement market performance of various segments pertaining to the North America Eye Health Supplement market.
- It provides Eye Health Supplement market revenue forecast of the market based on various segments for the period from 2019 to 2027.
NORTH AMERICA EYE HEALTH SUPPLEMENT MARKET SEGMENTATION
By Ingredient Type
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 fatty acids
- Coenzyme Q10
- Flavonoids
- Astaxanthin
- Alpha-Lipoic acid
- Others
By Indication
- Age-related macular degeneration (AMD)
- Cataract
- Dry eye syndrome
- Others
By Forms
- Tablet
- Capsule
- Drops
By Country
- US
- Canada
- Mexico
Company Profiles
- Nordic Naturals
- Herbalife Nutrition Ltd.
- The Nature's Bounty Co
- AMWAY
- Pfizer Inc.
- Alcon Inc.
- Bausch Health Companies Inc.
- Vitabiotics Ltd.
- Alliance Pharma PLC
- Allergan Plc.